Samsung Biologics will provide Kurma Partners with manufacturing, development, and de-risking services for biologics.

Samsung Biologics strikes manufacturing and development deal with Kurma

Chime Biologics, a contract development and manufacturing organization (CDMO), and Hope Medicine, a clinical-stage biotech company, announced plans to collaborate on development and manufacturing of monoclonal antibody drug HMI-115.

Chime Biologics, Hope Medicine Strike Manufacturing Deal

Samsung Biologics, Kurma Partners enter strategic partnership for development & manufacturing of biologics for Kurma’s portfolio companies: Incheon, South Korea Wednesday, Octob

Samsung Biologics, Kurma Partners enter strategic partnership for development & manufacturing of biologics for Kurma’s portfolio companies

Recorded Q3'23 consolidated revenue of KRW 1,034 billionRecorded Q3'23 consolidated operating profit of KRW 319 billionAchieved record-high

Samsung Biologics reports third quarter 2023 financial results

Samsung Biologics Co., the biotech arm of South Korea's Samsung Group, on Wednesday reported its third-quarter net profit jumped 86 percent from a year earlier, helped by long-term contracts with big pharmaceutical firms.

(LEAD) Samsung Biologics Q3 profit jumps 86 pct

Collaboration to focus on biologics of Kurma’s portfolio companies.

Samsung Biologics, Kurma Partners Strike Development and Manufacturing Deal

Rampart Bioscience, Inc. announces an $85M Series A financing to create medicines that aim to unburden patients from disease and their treatments.

Rampart Bioscience Announces $85M Series A Financing to Develop Novel DNA-Based Medicines with Veteran Team

Samsung Biologics has entered into a collaboration with Kurma Partners to develop biologics for Kurma's portfolio companies.

Samsung Biologics and Kurma collaborate for biologics development

Samsung Biologics said Tuesday it inked a partnership with Kurma Partners, a French venture capital firm specializing in financing health care companies, to offer a variety of drug-related services to Kurma Partners' portfolio companies.

Samsung Biologics to offer solutions for Kurma Partners' portfolio firms

SAMSUNG BIOLOGICS

Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.

SAMSUNG BIOLOGICS

samsungbiologics.com

employees

Since 2011

COMPANY RANKING

SAMSUNG BIOLOGICS

EVERGREEN INDEX #923

Representing this company? Click here to claim and customize this page!

Read More Tech Stories Related to #SAMSUNG BIOLOGICS

SAMSUNG BIOLOGICS WIKI

Apply to get your Tech Company News Page live on gzht888.com today!

SAMSUNG BIOLOGICS

samsungbiologics.com

employees

Since 2011

COMPANY RANKING

SAMSUNG BIOLOGICS

EVERGREEN INDEX #923

RELATED COMPANIESRANK

Representing this company? Click here to claim and customize this page!

Read More Tech Stories Related to #SAMSUNG BIOLOGICS

SAMSUNG BIOLOGICS WIKI

Apply to get your Tech Company News Page live on gzht888.com today!